ADIL Azora Therapeutics, Inc. (DE)

Fundamentals / CIK 0001513525 / USD
Other share classes on CIK 0001513525: AZR

Azora Therapeutics, Inc. (DE) reported $22.53M in total assets and a net loss of $120.6M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADIL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$0$0$0-$18.16MFY 2017 Net Income: -$1.14M2017FY 2018 Net Income: -$11.63M2018FY 2019 Net Income: -$8.59M2019FY 2020 Net Income: -$10.89M2020FY 2021 Net Income: -$19.42M2021FY 2022 Net Income: -$12.73M2022FY 2023 Net Income: -$5.12M2023FY 2024 Net Income: -$13.20M2024FY 2025 Net Income: -$7.98M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $2.62M $3.23M $1.27M $1.95M $8.40M $5.85M $3.97M $368K $182K
Total Operating Expenses $7.80M $8.28M $6.89M $10.86M $19.29M $10.93M $8.24M $6.99M $995K
Operating Income -$7.80M -$8.28M -$6.89M -$10.86M -$19.29M -$10.93M -$8.24M -$6.99M -$995K
Interest Income $150K $179K $70K $63K $6.5K $32K $95K $7.4K $367
Income Before Tax -$7.98M -$13.20M -$7.00M -$10.80M -$19.52M -$10.89M -$8.59M -$11.63M -$1.14M
Income Tax Expense -- -- -- -$502 -$94K -- -- -- --
Net Income -$7.98M -$13.20M -$5.12M -$12.73M -$19.42M -$10.89M -$8.59M -$11.63M -$1.14M
Basic EPS -$11.93 -$68.01 -$90.00 -$317.75 -$650.00 -$543.75 -$543.75 -$1,525.00 -$218.75
Diluted EPS -$11.93 -$68.01 -$90.00 -$317.75 -$650.00 -$543.75 -$543.75 -$1,525.00 -$218.75
Basic Shares Outstanding 668.6K 194.1K -- 40.1K 29.7K 19.9K 15.8K 7.6K 5.2K
Diluted Shares Outstanding 668.6K 194.1K 57.0K 40.1K 29.7K 19.9K 15.8K 389 279

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.77M $440K $433K $620K $521K $732K $747K $731K
Total Operating Expenses $7.53M $52.02M $2.00M $1.89M $1.76M $1.88M $2.27M $1.94M
Operating Income -$7.53M -$52.02M -$2.00M -$1.89M -$1.76M -$1.88M -$2.27M -$1.94M
Interest Income $170K $58K $47K $43K $48K $24K $35K $54K
Net Income -$64.56M -$51.99M -$2.02M -$2.00M -$1.79M -$1.96M -$2.23M -$2.07M
Basic EPS -$4.52 -$11.25 -$1.48 -- -$2.02 -$4.61 -$8.52 --
Diluted EPS -$4.52 -$11.25 -$1.48 -- -$2.02 -$4.61 -$8.52 --
Basic Shares Outstanding 14.3M 4.6M 1.4M -- 886.9K 424.9K 261.6K --
Diluted Shares Outstanding 14.3M 4.6M 1.4M -- 886.9K 424.9K 261.6K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.88M $3.75M $2.83M $4.00M $6.06M $4.40M $6.78M $3.87M $18K
Cash & Short-Term Investments $5.88M $3.75M $2.83M $4.00M $6.06M $4.40M $6.78M $3.87M $18K
Total Current Assets $6.18M $4.06M $3.20M $4.78M $6.46M $5.14M $7.67M $4.69M $27K
Property, Plant & Equipment, Net -- -- -- $50K $58K -- -- -- --
Goodwill -- -- -- $249K $249K -- -- -- --
Intangible Assets $3.0K $3.3K $3.9K $4.5K $5.0K $5.6K $6.2K $6.7K $7.3K
Other Non-Current Assets -- -- -- -- -- -- $6.2K $6.7K $7.3K
Total Non-Current Assets $493K $985K $1.54M $953K $1.01M $356K $6.2K $6.7K $7.3K
Total Assets $6.67M $5.04M $4.74M $5.73M $7.47M $5.49M $7.68M $4.70M $35K
Accounts Payable $655K $250K $103K $276K $286K $649K $190K $100K --
Other Current Liabilities -- -- -- $10K $9.7K -- -- -- --
Total Current Liabilities $1.40M $976K $653K $1.79M $2.72M $1.51M $539K $258K $1.03M
Total Non-Current Liabilities $0 $0 $0 $665K $1.24M $0 $0 $0 $0
Total Liabilities $1.40M $976K $653K $2.46M $3.97M $1.51M $539K $258K $1.03M
Total Debt (incl. Leases) -- -- -- $207K $464K -- -- -- --
Common Stock $1.0K $259 $1.7K $1.1K $21K $14K $10K $6.9K $3.3K
Retained Earnings -$89.97M -$82.00M -$68.80M -$63.67M -$50.94M -$31.52M -$20.63M -$12.04M -$404K
Total Stockholders' Equity $5.28M $4.07M $4.08M $3.28M $3.51M $3.99M $7.14M $4.44M -$998K
Total Equity $5.28M $4.07M $4.08M $3.28M $3.51M $3.99M $7.14M $4.44M -$998K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $22.00M -- -- $5.88M $4.61M $5.91M $2.37M $3.75M
Cash & Short-Term Investments $22.00M -- -- $5.88M $4.61M $5.91M $2.37M $3.75M
Total Current Assets $22.38M $28.84M $4.80M $6.18M $5.01M $6.08M $2.63M $4.06M
Intangible Assets $3.0K $3.0K $2.6K $3.0K $2.9K $3.1K $3.2K $3.3K
Total Non-Current Assets $151K $244K $424K $493K $646K $723K $822K $985K
Total Assets $22.53M $29.09M $5.23M $6.67M $5.66M $6.80M $3.45M $5.04M
Accounts Payable $1.39M $2.62M $574K $655K $556K $671K $532K $250K
Total Current Liabilities $5.06M $5.12M $1.51M $1.40M $1.15M $1.21M $1.32M $976K
Total Non-Current Liabilities $0 $23.81M $0 $0 $0 $0 $0 $0
Total Liabilities $5.06M $28.93M $1.51M $1.40M $1.15M $1.21M $1.32M $976K
Common Stock $3.0K $3.0K $1.5K $1.0K $24K $22K $6.7K $259
Retained Earnings -$208.5M -$144.0M -$91.99M -$89.97M -$87.98M -$86.18M -$84.22M -$82.00M
Total Stockholders' Equity -$21.06M -$38.38M $3.72M $5.28M $4.50M $5.59M $2.13M $4.07M
Total Equity -$21.06M -$38.38M $3.72M $5.28M $4.50M $5.59M $2.13M $4.07M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$7.98M -$13.20M -$5.12M -$12.73M -$19.42M -$10.89M -$8.59M -$11.63M -$1.14M
Stock-Based Compensation $676K $797K $1.75M $3.37M $4.24M $2.01M $1.60M $5.37M $205K
Change in Payables -- -- -$183K $16K -$354K $625K $91K -- --
Operating Cash Flow -$6.49M -$6.92M -$6.81M -$11.19M -$11.95M -$7.63M -$6.34M -$2.50M -$495K
Capital Expenditure -- -- -- -- -$65K -- -- -- --
Free Cash Flow -- -- -- -- -$12.01M -- -- -- --
Acquisitions, Net -- -- -- -- $31K -- -- -- --
Investing Cash Flow $150K -- $1.50M -- -$34K -$350K -- -- $35K
Common Stock Issued $3.66M $4.02M $750K $9.12M $11.75M $5.16M $8.20M $6.27M $40K
Share Repurchases -- -- -$1.7K -- -- -- -- -- --
Financing Cash Flow $8.47M $7.85M $4.13M $9.13M $13.64M $5.61M $9.25M $6.35M $390K
Net Change in Cash $2.13M $923K -$1.17M -$2.06M $1.66M -$2.38M $2.91M $3.85M -$70K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$64.56M -$51.99M -$2.02M -$2.00M -$1.79M -$1.96M -$2.23M -$2.07M
Stock-Based Compensation $958K $137K $148K $168K $147K $124K $237K $180K
Change in Payables -$1.20M $1.74M -$82K -- -$113K $138K $282K --
Operating Cash Flow -$6.63M -$6.36M -$1.61M -$1.32M -$1.83M -$1.75M -$1.59M -$1.45M
Investing Cash Flow -- -- -- $0 $0 $0 $150K --
Common Stock Issued $0 $850K $315K $54K $478K $3.08M $51K --
Financing Cash Flow -$35K $25.21M $315K $2.60M $525K $5.30M $51K $0
Net Change in Cash -$6.67M $24.13M -$1.30M $1.27M -$1.31M $3.55M -$1.38M -$1.45M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -151.2% -324.4% -125.5% -388.6% -553.7% -273.3% -120.3% -261.9% --
Return on Assets (ROA) -119.5% -261.6% -108.2% -222.1% -259.8% -198.4% -111.9% -247.5% -3298.4%
Current Ratio 4.42x 4.16x 4.90x 2.67x 2.37x 3.41x 14.24x 18.19x 0.03x
Quick Ratio 4.21x 3.84x 4.33x 2.23x 2.23x 2.92x 12.57x 15.00x 0.02x
Debt to Equity -- -- -- 0.06x 0.13x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -209.1% -151.2% -178.7% -151.2% -421.0% -324.4%
Return on Assets (ROA) -535.2% -198.7% -148.7% -119.5% -142.3% -124.2% -259.3% -261.6%
Current Ratio 4.43x 5.63x 3.18x 4.42x 4.34x 5.02x 1.99x 4.16x
Quick Ratio 4.35x -- -- 4.21x 3.99x 4.88x 1.79x 3.84x
Source: SEC EDGAR CompanyFacts (CIK 0001513525) · from June 30, 2017 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal